These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2355641)

  • 1. [2D3 series, MSW 113 and other monoclonal antibodies directed to type 1 chain carbohydrate antigens].
    Kannagi R; Takada A; Shigeta K; Itai S; Hashimoto K
    Nihon Rinsho; 1990 Feb; 48 Suppl():992-8. PubMed ID: 2355641
    [No Abstract]   [Full Text] [Related]  

  • 2. [2 --> 6 sialyl Le(a) antigen].
    Miyazaki K; Kannagi R
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():703-8. PubMed ID: 20960854
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of ST 272 Ag detected by the monoclonal antibody, NCC-ST-272].
    Sekine T
    Nihon Rinsho; 1990 Feb; 48 Suppl():1028-30. PubMed ID: 2192104
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of TAC-41 assay as a tumor marker].
    Ariyoshi Y; Kuwabara M; Iwakoshi N; Kito K
    Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
    [No Abstract]   [Full Text] [Related]  

  • 5. [Carbohydrate antigens as a tumor-associated antigen and prognostic indicators in carcinomas of the breast, esophagus, stomach, colorectum, and pancreas].
    Watanabe T; Asai H; Sakamoto J; Narita T; Ichihara T; Yamauchi M; Takagi H
    Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1098-101. PubMed ID: 1944163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
    Sugano K; Okura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor markers in pancreatic cancer--current concepts.
    Schmiegel W
    Hepatogastroenterology; 1989 Dec; 36(6):446-9. PubMed ID: 2693300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigens associated with cancer of the pancreas].
    Burtin P
    Bull Cancer; 1990; 77(1):69-73. PubMed ID: 2317577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serologic diagnosis of digestive tract cancer].
    Wada T; Imai K
    Gan No Rinsho; 1986 Aug; 32(10):1065-8. PubMed ID: 3783934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of pancreatic carcinoma using 2 associated monoclonal antibodies].
    Yao CZ; Zeng XJ; Wang SZ
    Zhonghua Wai Ke Za Zhi; 1987 Nov; 25(11):655-8, 670. PubMed ID: 3482539
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cancer-associated carbohydrate antigens in digestive cancers].
    Sawabu N; Kawakami H; Watanabe H; Satomura Y
    Rinsho Byori; 1989 May; 37(5):509-16. PubMed ID: 2770006
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monoclonal antibodies. Their usefulness in the diagnosis of malignant tumors of the digestive system].
    Campos Campos F; Romero Navarro MA; Gutiérrez Samperio C; Esquivel P; Gaviño Chapa JF
    Rev Gastroenterol Mex; 1989; 54(4):193-8. PubMed ID: 2616981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New monoclonal antibodies in the diagnosis of gastrointestinal cancers].
    Heptner G; Domschke S; Domschke W
    Internist (Berl); 1986 Nov; 27(11):723-8. PubMed ID: 2433247
    [No Abstract]   [Full Text] [Related]  

  • 14. [2-->6 Sialyl Le(a) antigen].
    Miyazaki K; Kannagi R
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():663-8. PubMed ID: 16149606
    [No Abstract]   [Full Text] [Related]  

  • 15. Stage-specific expression of cancer-associated type 1 and type 2 chain polylactosamine antigens in the developing pancreas of human embryos.
    Tuo XH; Itai S; Nishikata J; Mori T; Tanaka O; Kannagi R
    Cancer Res; 1992 Oct; 52(20):5744-51. PubMed ID: 1394198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of carbohydrate antigen 19-9 assay as a tumor marker].
    Ohkura H; Sakawaki T; Hara K; Mitsuhashi F
    Nihon Rinsho; 1990 Feb; 48 Suppl():931-3. PubMed ID: 2192177
    [No Abstract]   [Full Text] [Related]  

  • 17. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
    Huang C; Bei L; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum level of tumor markers (antigen Ca 19-9, CEA, ferritin) in digestive tumors. Their diagnostic usefulness].
    Jovin G; Stănel I; Popovici I; Oproiu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):223-9. PubMed ID: 2904162
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic value of serum CA 19-9 determination in digestive tract cancer].
    Chen SB
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):58-60. PubMed ID: 2364873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CA19-9, CA242].
    Odagiri E
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():685-7. PubMed ID: 20960851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.